Current best practices and rationalistic perspectives in causation-based prevention, early detection and multidisciplinary treatment of breast and gastric cancer

Gastric & Breast Cancer
DOI: 10.2122/gbc.2003.0025


Highly Effective Treatment for Serosa-Negative Gastric Cancer
Scientific evidence provides a latest Japanese randomized controlled trial (RCT) indicating that if patients with serosa-negative cancer, even at presence of lymph nodes metastases, treated appropriately with a complete and effective D2 node dissection, they have a very high probability of cure.

Given the moderate prognosis of the patients with this tumor-specific tumor stage in the West, could a Japanese-style treatment approach improve the clinical outcomes of these patients in the USA and Europe? How feasible is this treatment strategy and what are the limitations for a wide clinical use in the West? Research focus on innovative-agents development or surgeon’s education on appropriate D2 dissection is the most effective way of western public-health care towards improvement of the outcomes of patients with early-stage gastric cancer?

Online ISSN : 1109 - 7647
   Print ISSN : 1109 - 7655

We subscribe to the HONcode principles of the HON Foundation. Click to verify. We subscribe to the HONcode principles. Verify here.
please, read our policy about privacy and confidentiality of information and transparency of sponsorship

last update: 22 May 2003